EFSA J. 2021 Mar 26;19(3):e06543. doi: 10.2903/j.efsa.2021.6543. eCollection 2021 Mar.
[Table: see text] Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on Scientific and technical guidance for the preparation and presentation of applications for exemption from mandatory labelling of food allergens and/or products thereof. This guidance applies to food ingredients or substances with known allergenic potential listed in Annex II of Regulation (EU) No 1169/2011 or products thereof, and aims to assist applicants in the preparation and presentation of well-structured applications for exemption from labelling. It presents a common format for the organisation of the information to be provided and outlines the information and scientific data which must be included in the application, the hierarchy of different types of data and study designs, reflecting the relative strength of evidence which may be obtained from different study types and the key issues which must be addressed in the application in order to assess the likelihood of a food allergen-derived preparation/foodstuff(s) triggering adverse reactions in sensitive individuals under the proposed conditions of use. This guidance document was adopted by the NDA Panel in 2013 and updated in 2017 to reflect the application of Regulation (EU) No 1169/2011. Upon request from the European Commission in 2020, it has been revised to inform applicants of new provisions in the pre-submission phase and submission application procedure set out in Regulation (EC) No 178/2002, as amended by Regulation (EU) 2019/1381 on the transparency and sustainability of the EU risk assessment in the food chain, that are applicable to all applications submitted as of 27 March 2021.
[表:见正文] 应欧盟委员会的要求,欧洲食品安全局(EFSA)的营养产品、营养与过敏专家组(NDA)被要求就食品过敏原和/或其产品强制标签豁免申请的制备和提交的科学技术指南发表科学意见。本指南适用于欧盟第1169/2011号法规附件II中列出的具有已知致敏潜力的食品成分或物质及其产品,旨在协助申请人制备和提交结构良好的标签豁免申请。它提供了一种组织待提供信息的通用格式,并概述了申请中必须包含的信息和科学数据、不同类型数据和研究设计的层次结构,反映了从不同研究类型中可能获得的证据的相对强度,以及申请中为评估食品过敏原衍生制剂/食品在拟议使用条件下引发敏感个体不良反应的可能性而必须解决的关键问题。本指南文件由NDA专家组于2013年通过,并于2017年更新以反映欧盟第1169/2011号法规的应用。应欧盟委员会2020年的要求,对其进行了修订,以告知申请人《欧盟第178/2002号法规》(经《欧盟2019/1381号法规》修订,涉及欧盟食品链风险评估的透明度和可持续性)中预提交阶段和提交申请程序的新规定,这些规定适用于自2021年3月27日起提交的所有申请。